Conference Update:

ADA 2022: Spotlight on Real-World Evidence Supporting the Use of Real-Time Continuous Glucose Monitoring

Click here for a summary of key posters that highlight findings on the value of rtCGM pertinent to managed care and payer decision makers.

Featured Resource:

Highlights From a CGM Expert Interview With Thomas Grace, MD

In the second installment in a new series of video resources hosted on ManagedCareCGM.com, Dr. Thomas Grace, Medical Director at the Blanchard Valley Diabetes Center in Findlay, Ohio, describes the steps taken to implement a rtCGM-centered management program and the clinical utility of rtCGM in primary care.

Click here for the full interview.

 

Featured Article:

Use of real-time CGM linked to lower health care costs in type 2 diabetes

Real-world data show that rtCGM initiation resulted in savings of $424 per member per month (PMPM), driven by a decrease in inpatient hospitalization costs among users with T2D. This retrospective claims analysis adds to the mounting body of evidence demonstrating the value of rtCGM in T2D for improving outcomes and reducing health care resource utilization among plan members.

In The News:

FDA Grants Breakthrough Device Designation for Dexcom Hospital CGM System

 

Featured Publications

 

		Rethinking Diabetes Care In The Digital Age – Findings from the 2021 Digital Quality Summit
		Expanding Medicaid Access to Continuous Glucose Monitors
		Emerging Landscape of Continuous Glucose Monitoring Diabetes Technology & Therapeutics
		Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes The Journal of the American Medical Association
		Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicenter, randomized controlled trial The Lancet
		Effect of Continuous Glucose Monitoring on Glycemic Control in Patients with Type 2 Diabetes Treated with Basal Insulin: A Randomized Clinical Trial The Journal of the American Medical Association

 

Recent News

		CMS revised Medicare coverage criteria for therapeutic CGMs. Most notably, eliminating a requirement that beneficiaries use four fingerstick tests per day prior to accessing CGM. Effective July 18, 2021. Centers for Medicare & Medicaid Services
		Real-time CGM lowers HbA1c, reduces ED visits in insulin-treated diabetes Endocrine Today